Development and evaluation of a prediction model for peripheral artery disease-related major adverse limb events using novel biomarker data
Journal of Vascular Surgery · 2024
DOI: 10.1016/j.jvs.2024.03.450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2024. Verfasst von Ben Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Division of Vascular Surgery, St. Michael's Hospital, Unity Health Toronto, U…. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Biomarkers, Predictive Value of Tests, Natriuretic Peptide, Brain. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Prognostic tools for individuals with peripheral artery disease (PAD) remain limited. We developed prediction models for 3-year PAD-related major adverse limb events (MALE) using demographic, clinical, and biomarker data previously validated by our group. METHODS: We performed a prognostic study using a prospectively recruited cohort of patients with PAD (n = 569). Demographic/clinical data were recorded including sex, age, comorbidities, previous procedures, and medications. Plasma concentrations of three biomarkers (N-terminal pro-B-type natriuretic peptide [NT-proBNP], fatty acid binding protein 3 [FABP3], and FABP4) were measured at baseline. The cohort was followed for 3 years. MALE was the primary outcome (composite of open/endovascular vascular intervention or major amputation). We trained three machine learning models with 10-fold cross-validation using demographic, clinical, and biomarker data (random forest, decision trees, and Extreme Gradient Boosting [XGBoost]) to predict 3-year MALE in patients. Area under the receiver operating characteristic curve (AUROC) was the primary model evaluation metric. RESULTS: Three-year MALE was observed in 162 patients (29%). XGBoost was the top-performing predictive model for 3-year MALE, achieving the following performance metrics: AUROC = 0.88 (95% confidence interval [CI], 0.84-0.94); sensitivity, 88%; specificity, 84%; positive predictive value, 83%; and negative predictive value, 91% on test set data. On an independent validation cohort of patients with PAD, XGBoost attained an AUROC of 0.87 (95% CI, 0.82-0.90). The 10 most important predictors of 3-year MALE consisted of: (1) FABP3; (2) FABP4; (3) age; (4) NT-proBNP; (5) active smoking; (6) diabetes; (7) hypertension; (8) dyslipidemia; (9) coronary artery disease; and (10) sex. CONCLUSIONS: We built robust machine learning algorithms that accurately predict 3-year MALE in patients with PAD using demographic, clinical, and novel biomarker data. Our algorithms can support risk stratification of patients with PAD for additional vascular evaluation and early aggressive medical management, thereby improving outcomes. Further validation of our models for clinical implementation is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Division of Vascular Surgery, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada; Institute of Medical S…
- Division of Vascular Surgery, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada; Division of Vascular Surgery, American University of Beirut Medical Center, Beirut, Lebanon.
- Division of Vascular Surgery, St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada.
- Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Temerty Centre for Artificial Intelligence Research and Education in Medicine (T-CAIREM), University of Toronto, Toronto, Ontario, Canada; D…
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Zitieren
APA
Li, B., Nassereldine, R., Zamzam, A., Syed, M. H., Mamdani, M., Al-Omran, M., Abdin, R., & Qadura, M. (2024). Development and evaluation of a prediction model for peripheral artery disease-related major adverse limb events using novel biomarker data. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2024.03.450
Vancouver
Li B, Nassereldine R, Zamzam A, Syed MH, Mamdani M, Al-Omran M, et al. Development and evaluation of a prediction model for peripheral artery disease-related major adverse limb events using novel biomarker data. Journal of Vascular Surgery. 2024. doi:10.1016/j.jvs.2024.03.450
BibTeX
@article{Li2024,
author = {Li, Ben and Nassereldine, Rakan and Zamzam, Abdelrahman and Syed, Muzammil H and Mamdani, Muhammad and Al-Omran, Mohammed and Abdin, Rawand and Qadura, Mohammad},
title = {Development and evaluation of a prediction model for peripheral artery disease-related major adverse limb events using novel biomarker data},
journal = {Journal of Vascular Surgery},
year = {2024},
doi = {10.1016/j.jvs.2024.03.450}
}
EUVIMED